Arthur M. Cohen & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$11.2M |
| 2 |
Apple
AAPL
|
+$10.3M |
| 3 |
Amazon
AMZN
|
+$4.37M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$1.56M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$7.11M |
| 2 |
Procter & Gamble
PG
|
+$1.37M |
| 3 |
Colgate-Palmolive
CL
|
+$1.33M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$723K |
| 5 |
ExxonMobil
XOM
|
+$616K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.13% |
| 2 | Financials | 20.45% |
| 3 | Consumer Staples | 16.96% |
| 4 | Technology | 7.65% |
| 5 | Industrials | 6.09% |
Similar funds
Arthur M. Cohen & Associates's Q1 2017 Portfolio in Review
As of Q1 2017, Arthur M. Cohen & Associates held 104 positions worth $224M, up 18% from $189M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Arthur M. Cohen & Associates deployed $20.9M of net new capital in Q1 2017, opening 8 new positions and adding to 40 existing holdings. Its largest new stake was Amgen: 67,669 shares worth $11.1M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was Procter & Gamble, an estimated $1.37M trimmed.
- Arthur M. Cohen & Associates's largest Q1 2017 buy was Amgen: 67,669 shares worth $11.1M.
- Arthur M. Cohen & Associates added most to Bristol-Myers Squibb in Q1 2017, an estimated $1.56M increase.
- Arthur M. Cohen & Associates's biggest Q1 2017 reduction was Procter & Gamble, cutting an estimated $1.37M.
- Arthur M. Cohen & Associates fully exited Fortive in Q1 2017, selling an estimated $7.11M.
- Arthur M. Cohen & Associates's ten largest holdings make up 53% of its $224M portfolio in Q1 2017.
- Arthur M. Cohen & Associates opened 8 new positions and closed 10 in Q1 2017.
- Arthur M. Cohen & Associates's portfolio value rose 18% quarter-over-quarter to $224M.
Based on Arthur M. Cohen & Associates's 13F filing for Q1 2017, filed 10 May 2017.